On April 2, 2026, the President of the United States signed a Presidential Proclamation introducing significant tariffs on imports of patented pharmaceutical articles and their ingredients into the United States.
08
Apr
On April 2, 2026, the President of the United States signed a Presidential Proclamation introducing significant tariffs on imports of patented pharmaceutical articles and their ingredients into the United States.